Population (P): Adults (19 years), both males and females, either healthy or diagnosed with chronic metabolic or inflammatory conditions (e.g., type 2 diabetes, polycystic ovary syndrome, obesity, cardiovascular diseases, arthritis, or ocular disorders)
Cochrane Database System Rev 2008;(1):CD006893
Toxicol In Vitro
Benefits of BPC-157 for Recovery and Performance BPC-157 is a stable gastric pentadecapeptide with robust preclinical evidence in GI protection and musculoskeletal repairparticularly tendons and ligaments
Novo Nordisk, meanwhile, is offering a cheaper, cash-pay version of Wegovy, available direct to consumer through its new NovoCare Pharmacy